Year
2023
-
Viriom Launches Reproductive Toxicity Studies for Elpida®
-
Viriom Launches Reproductive Toxicity Studies for Elpida®
-
Viriom Launches Reproductive Toxicity Studies for Elpida®
-
Viriom, Inc. has announced the start of a Phase 2 clinical trial in adults with moderate manifestations of COVID-19
-
Viriom, Inc. has announced the start of a Phase 2 clinical trial in adults with moderate manifestations of COVID-19
-
Viriom, Inc. has announced the start of a Phase 2 clinical trial in adults with moderate manifestations of COVID-19
-
ChemDiv, Inc. opens a unique store of low-molecular-weight drugs
-
ChemDiv, Inc. opens a unique store of low-molecular-weight drugs
-
ChemDiv, Inc. opens a unique store of low-molecular-weight drugs
-
ChemDiv has created a unique TM KATO platform